Amobarbital (Compound)

Synonyms:amobarbital, Amylobarbitone, Barbamyl, Amylobarbital, Barbamil, Pentymal, Amytal, 57-43-2, Amobarbitone, Amylbarbitone, Eunoctal, Isomytal, Talamo, Barbamyl acid, Binoctal, Dorlotyn, Dormytal, Mylodorm, Pentymalum, Schiwanox, Sednotic, Stadadorm, Amasust, Amital, Amospan, Amybal, Robarb, Somnal, Sumital, Isomyl, AMAL, Isoamylethylbarbituric acid, Ethylisopentylbarbituric acid, 5-Ethyl-5-isoamylbarbituric acid, 5-Ethyl-5-isopentylbarbituric acid, 5-Ethyl-5-isoamylmalonyl urea, 5-Ethyl-5-(3-methylbutyl)barbituric acid, 5-Isoamyl-5-ethylbarbituric acid, Barbituric acid, 5-ethyl-5-isopentyl-, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, NSC 10815, 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione, UNII-GWH6IJ239E, component of Dexamyl, component of Q-Caps, component of 15-90, component of Amo-Dextrosule, GWH6IJ239E, CHEBI:2673, 5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione, NSC-10815, NCGC00247711-01, Amobarbitale, Amobarbitalum, Amobarbitale [DCIT], Amobarbitalum [INN-Latin], 5-Ethyl-5-isopentylbarbitursaeure, DEA No. 2125, WLN: T6VMVMV FHJ F2 F2Y1&1, Isomytal (TN), CCRIS 5454, HSDB 3286, EINECS 200-330-7, 2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, 5-Ethyl-5-(3-methylbutyl)-2,6(1H,3H,5H)-pyrimidinetrione, Amobarbital cii, Amobarbital [USP:INN:BAN:JAN], Dexamyl (Salt/Mix), DSSTox_CID_81, Amobarbital (JP17/INN), DSSTox_RID_75353, BIDD:PXR0091, DSSTox_GSID_20081, Oprea1_587446, SCHEMBL43780, CBDivE_006514, DivK1c_000994, CHEMBL267894, DTXSID9020081, SCHEMBL15364946, component of Dexamyl (Salt/Mix), KBio1_000994, VIROVYVQCGLCII-UHFFFAOYSA-, component of Q-Caps (Salt/Mix), NINDS_000994, component of 15-90 (Salt/Mix), Amobarbital 0.1 mg/ml in Methanol, Amobarbital 1.0 mg/ml in Methanol, NSC10815, NSC32406, ZINC4811698, Tox21_112866, NSC-32406, NSC120800, Barbituric acid, 5-ethyl-5-isoamyl-, DB01351, NSC-120800, CAS-57-43-2, component of Amo-Dextrosule (Salt/Mix)

Pubchem:PUBCHEM:2164

Id:f660a33d-2280-53dc-b36f-bd812ca1ef28

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Amobarbital's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Amobarbital.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Amobarbital.

Results found

Linked to

	Label	Description
	DCSTRUCT ID 00184 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00184; PubChem_CID:2164, FILE=drugcentral_drug_00184.json)
	amobarbital (2936bef0-f7dd-486b-9e12-0b73ce17aea1) Collection (Entity type)	Metadatata for amobarbital
	Amobarbital indication Status Epilepticus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Epilepsy Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Seizure disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Severe anxiety (panic) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Sleeplessness Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication General Anesthesia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Narcoanalysis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Amobarbital indication Local anesthesia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG